Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues-Reference-Cited by-同舟云学术

Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues

Published:2007-01 Issue:1 Volume:34 Page:17-28
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

García Garayoa Elisa,Rüegg Dominique,Bläuenstein Peter,Zwimpfer Martin,Khan Irfan Ullah,Maes Veronique,Blanc Alain,Beck-Sickinger Annette G.,Tourwé Dirk A.,Schubiger P. August

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference36 articles.

1. A ticket to ride: peptide radiopharmaceuticals;Fischman;J Nucl Med,1993

2. Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms;McAfee;Nucl Med Biol,1996

3. Receptor targeting for tumor localisation and therapy with radiopeptides;Heppeler;Curr Med Chem,2000

4. Peptide radiopharmaceuticals for diagnosis and therapy;Signore;Eur J Nucl Med,2001

5. Peptide receptors as molecular targets for cancer diagnosis and therapy;Reubi;Endocrine Rev,2003

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-Acetylation of Biodegradable Supramolecular Peptide Nanofilaments Selectively Enhances Their Proteolytic Stability for Targeted Delivery of Gold-Based Anticancer Agents;ACS Biomaterials Science & Engineering;2023-05-16

2. Technetium(I) carbonyl complexes for nuclear medicine: Coordination-chemical aspect;Coordination Chemistry Reviews;2023-02

3. Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (99mTc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor;ACS Omega;2021-01-08

4. 99m Tc Radiopharmaceutical Chemistry;Handbook of Radiopharmaceuticals;2020-12-21

5. A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models;Nuclear Medicine and Biology;2020-11